DEMENTIA FRONTOTEMPORAL
Clinical trials for DEMENTIA FRONTOTEMPORAL explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA FRONTOTEMPORAL trials appear
Sign up with your email to follow new studies for DEMENTIA FRONTOTEMPORAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial hopes to halt rare dementia
Disease control Recruiting nowThis study tests a one-time gene therapy called AVB-101 for people with a specific genetic form of frontotemporal dementia (FTD-GRN). The therapy is injected directly into the brain to restore a missing protein and potentially slow or stop the disease. 18 adults aged 30-75 with e…
Matched conditions: DEMENTIA FRONTOTEMPORAL
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Bilingual brain power: can two languages boost aphasia recovery?
Knowledge-focused Recruiting nowThis study looks at how speaking two languages (Spanish and English or Spanish and Catalan) affects language treatment in people with primary progressive aphasia (PPA), a condition that first causes speech and language problems. Researchers will give tailored speech therapy in bo…
Matched conditions: DEMENTIA FRONTOTEMPORAL
Phase: NA • Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated May 26, 2026 05:21 UTC